Characterization of TROP-2 bispecific T cell engagers for immunotherapy of triple negative breast and bladder cancer

T cell-based immunotherapy has markedly expanded the therapeutic options in numerous cancers. However, these approaches still achieve only limited clinical benefit in triple negative breast cancer (TNBC) and bladder cancer. Although immune checkpoint inhibitors improve outcomes for a subset of patie...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Carlos Ávila-Nieto, Gundram Jung, Helmut R. Salih, Ilona Hagelstein
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2026-03-01
Serier:	Frontiers in Immunology
Fag:	immunotherapy triple negative breast cancer bladder cancer TROP-2 CD3 bispecific antibody
Online adgang:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1794705/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!